Skip to main content
Erschienen in: Journal of Neuro-Oncology 1/2008

01.03.2008 | Clinical-Patient Studies

A case of atypical thyrotroph cell adenoma, which re-grew within 3 months after surgery and required multimodal treatment

verfasst von: Yoshikazu Ogawa, Teiji Tominaga

Erschienen in: Journal of Neuro-Oncology | Ausgabe 1/2008

Einloggen, um Zugang zu erhalten

Abstract

Objective and importance Thyrotroph cell adenoma accounts for only 1% of all pituitary adenomas. This tumor is tough and firm because of significant interstitial fibrosis, and is difficult to remove. Atypical adenoma has an aggressive biological character, invades the surrounding structures, and grows rapidly. Atypical thyrotroph cell adenoma is extremely rare. Clinical presentation A 32-year-old man presented with hyperthyroidism and bitemporal hemianopsia. Head magnetic resonance imaging revealed a large sellar tumor compressing the optic chiasma and invading the left cavernous sinus. Intervention Transsphenoidal surgery was performed and subtotal removal was achieved. Histological examination showed atypical thyrotroph cell adenoma. Gamma knife surgery was planned, but the tumor re-grew within 3 months, and reattached to the optic chiasma. Second transcranial surgery failed to remove residual tumor behind the pituitary stalk. Conventional irradiation followed by octreotide administration resulted in decreased tumor size and stable euthyroidism. The tumor has been controlled for 22 months since first surgery and diagnosis. Conclusion Atypical thyrotroph cell adenoma has an aggressive biological character and grows rapidly. Multimodal treatment including medication and radiotherapy is required.
Literatur
1.
Zurück zum Zitat Bertholon-Greoire M, Trouillas J, Guigard MP, Loras B, Tourniaire J (1999) Mono- and plurihormonal thyrotropic pituitary adenomas: pathological, hormonal and clinical studies in 12 patients. Eur J Endocrinol 140:519–527CrossRef Bertholon-Greoire M, Trouillas J, Guigard MP, Loras B, Tourniaire J (1999) Mono- and plurihormonal thyrotropic pituitary adenomas: pathological, hormonal and clinical studies in 12 patients. Eur J Endocrinol 140:519–527CrossRef
2.
Zurück zum Zitat Delellis RA, Lloyd RV, Heitz PU, Eng C (eds) (2004) Pathology and genetics of tumors of endocrine organs. International Agency for Research on Cancer, Lyon Delellis RA, Lloyd RV, Heitz PU, Eng C (eds) (2004) Pathology and genetics of tumors of endocrine organs. International Agency for Research on Cancer, Lyon
3.
Zurück zum Zitat Kovacs K, Horvath E (eds) (1986) Tumors of the pituitary gland, 2nd series. Armed Forces Institute of Pathology, Washington Kovacs K, Horvath E (eds) (1986) Tumors of the pituitary gland, 2nd series. Armed Forces Institute of Pathology, Washington
4.
Zurück zum Zitat Socin HV, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J, Stevenaert A, Beckers A (2003) The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol 148:433–442PubMedCrossRef Socin HV, Chanson P, Delemer B, Tabarin A, Rohmer V, Mockel J, Stevenaert A, Beckers A (2003) The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. Eur J Endocrinol 148:433–442PubMedCrossRef
5.
Zurück zum Zitat Sanno N, Teramoto A, Osamura Y (2001) Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment. J Neurooncol 54:179–186PubMedCrossRef Sanno N, Teramoto A, Osamura Y (2001) Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment. J Neurooncol 54:179–186PubMedCrossRef
6.
Zurück zum Zitat Lloyd RV, Kovacs K, Young WF Jr, Farrel WE, Asa SL, Trouillas J, Kontogeorgos G, Sano T, Scheithauer BW, Horvath E (2004) Pituitary tumours: introduction. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) WHO classification of tumours. Pathology and genetics. Tumours of endocrine organs. IARC Press, Lyon, pp 10–13 Lloyd RV, Kovacs K, Young WF Jr, Farrel WE, Asa SL, Trouillas J, Kontogeorgos G, Sano T, Scheithauer BW, Horvath E (2004) Pituitary tumours: introduction. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) WHO classification of tumours. Pathology and genetics. Tumours of endocrine organs. IARC Press, Lyon, pp 10–13
7.
8.
Zurück zum Zitat Kontogeorgos G (2006) Predictive markers of pituitary adenoma behavior. Neuroendocrinology 83:179–188PubMedCrossRef Kontogeorgos G (2006) Predictive markers of pituitary adenoma behavior. Neuroendocrinology 83:179–188PubMedCrossRef
9.
Zurück zum Zitat Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German pituitary tumor registry. Eur J Endocrinol 156:203–216PubMedCrossRef Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S (2007) Pathohistological classification of pituitary tumors: 10 years of experience with the German pituitary tumor registry. Eur J Endocrinol 156:203–216PubMedCrossRef
10.
Zurück zum Zitat Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws ER Jr (1996) P53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 38:765–771PubMedCrossRef Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws ER Jr (1996) P53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 38:765–771PubMedCrossRef
11.
Zurück zum Zitat Ikeda H, Ogawa Y, Yoshimoto T (1999) Ultrastructural characteristics of TSH-producing adenomas with special reference to its close similarity to BFA-treated pituitary adenoma cells. Pituitary 1:221–226PubMedCrossRef Ikeda H, Ogawa Y, Yoshimoto T (1999) Ultrastructural characteristics of TSH-producing adenomas with special reference to its close similarity to BFA-treated pituitary adenoma cells. Pituitary 1:221–226PubMedCrossRef
12.
Zurück zum Zitat Ogawa Y, Ikeda H, Yoshimoto T (1996) Ultrastructural changes in cells of human pituitary adenoma treated by Brefeldin A. Jpn J Clin Electron Microsc 29:69–75 Ogawa Y, Ikeda H, Yoshimoto T (1996) Ultrastructural changes in cells of human pituitary adenoma treated by Brefeldin A. Jpn J Clin Electron Microsc 29:69–75
13.
Zurück zum Zitat Ogawa Y, Tominaga T, Ikeda H (2007) Intrasellar small TSH secreting pituitary adenomas, 2 case reports. No Shinkei Geka 35:679–684PubMed Ogawa Y, Tominaga T, Ikeda H (2007) Intrasellar small TSH secreting pituitary adenomas, 2 case reports. No Shinkei Geka 35:679–684PubMed
14.
Zurück zum Zitat Brucker-Davis F, Oldfield EH, Skarulis MC, Doppman JL, Weintraub BD (1999) Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 84:476–486PubMedCrossRef Brucker-Davis F, Oldfield EH, Skarulis MC, Doppman JL, Weintraub BD (1999) Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health. J Clin Endocrinol Metab 84:476–486PubMedCrossRef
15.
Zurück zum Zitat Patrick AW, Atkin SL, MacKenzie J, Foy PM, White MC, MacFarlane IA (1994) Hyperthyroidism secondary to a pituitary adenoma secreting TSH, FSH alpha-subunit and GH. Clin Endocrinol (Oxf) 40:275–278 Patrick AW, Atkin SL, MacKenzie J, Foy PM, White MC, MacFarlane IA (1994) Hyperthyroidism secondary to a pituitary adenoma secreting TSH, FSH alpha-subunit and GH. Clin Endocrinol (Oxf) 40:275–278
16.
Zurück zum Zitat Sanno N, Teramoto A, Osamura Y (2000) Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma. J Neurosurg 93:194–200PubMedCrossRef Sanno N, Teramoto A, Osamura Y (2000) Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma. J Neurosurg 93:194–200PubMedCrossRef
17.
Zurück zum Zitat Beck-Peccoz P, Persani L (2002) Medical management of thyrotropin-secreting pituitary adenomas. Pituitary 5:83–88PubMedCrossRef Beck-Peccoz P, Persani L (2002) Medical management of thyrotropin-secreting pituitary adenomas. Pituitary 5:83–88PubMedCrossRef
18.
Zurück zum Zitat Caron P, Arlot S, Bauters C, Chanson P, Kuhn JM, Pugeat M, Marechaud R, Teutsch C, Vidal E, Sassano P (2001) Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 86:2849–2853PubMedCrossRef Caron P, Arlot S, Bauters C, Chanson P, Kuhn JM, Pugeat M, Marechaud R, Teutsch C, Vidal E, Sassano P (2001) Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab 86:2849–2853PubMedCrossRef
19.
Zurück zum Zitat Dhillon KS, Cohan P, Kelly DF, Darwin CH, Iyer KV, Chopra IJ (2004) Treatment of hyperthyroidism associated with thyrotropin-secreting pituitary adenomas with iopanoic acid. J Clin Endocrinol Metab 89:708–711PubMedCrossRef Dhillon KS, Cohan P, Kelly DF, Darwin CH, Iyer KV, Chopra IJ (2004) Treatment of hyperthyroidism associated with thyrotropin-secreting pituitary adenomas with iopanoic acid. J Clin Endocrinol Metab 89:708–711PubMedCrossRef
20.
Zurück zum Zitat Mixson AJ, Friedman TC, David AK (1993) Thyrotropin-secreting pituitary carcinoma. J Clin Endocrinol Metab 76:529–533PubMedCrossRef Mixson AJ, Friedman TC, David AK (1993) Thyrotropin-secreting pituitary carcinoma. J Clin Endocrinol Metab 76:529–533PubMedCrossRef
Metadaten
Titel
A case of atypical thyrotroph cell adenoma, which re-grew within 3 months after surgery and required multimodal treatment
verfasst von
Yoshikazu Ogawa
Teiji Tominaga
Publikationsdatum
01.03.2008
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 1/2008
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-007-9492-2

Weitere Artikel der Ausgabe 1/2008

Journal of Neuro-Oncology 1/2008 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.